Selected research
Industry Research
Whole Cell Cholera Vaccine Industry Research Report 2026
Market perspective
The global Whole Cell Cholera Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Whole Cell Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Whole Cell Cholera Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Whole Cell Cholera Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Whole Cell Cholera Vaccine include Johnson and Johnson, Merck, Pfizer, GlaxoSmithKline, Valneva SE, Serum Institute of India, SBL Vaccine, Sanofi Pasteur and PaxVax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Whole Cell Cholera Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Whole Cell Cholera Vaccine Market by Company
Johnson and Johnson
Merck
Pfizer
GlaxoSmithKline
Valneva SE
Serum Institute of India
SBL Vaccine
Sanofi Pasteur
PaxVax
AstraZeneca(Medimmune, LLC.)
Whole Cell Cholera Vaccine Segment by Type
For Adults
For Children
Whole Cell Cholera Vaccine Segment by Application
Hospital
Surgical Centers
Clinical Research Institutes
Others
Whole Cell Cholera Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Cell Cholera Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Cell Cholera Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Cell Cholera Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Whole Cell Cholera Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Whole Cell Cholera Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Whole Cell Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- For Adults
- For Children
Applications
- Hospital
- Surgical Centers
- Clinical Research Institutes
- Others
Companies covered
- Johnson and Johnson
- Merck
- Pfizer
- GlaxoSmithKline
- Valneva SE
- Serum Institute of India
- SBL Vaccine
- Sanofi Pasteur
- PaxVax
- AstraZeneca(Medimmune, LLC.)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Whole Cell Cholera Vaccine Market Size (2021-2032)
- 2.2.2 Global Whole Cell Cholera Vaccine Sales (2021-2032)
- 2.2.3 Global Whole Cell Cholera Vaccine Market Average Price (2021-2032)
- 2.3 Whole Cell Cholera Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 For Adults
- 2.3.3 For Children
- 2.4 Whole Cell Cholera Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Surgical Centers
- 2.4.4 Clinical Research Institutes
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Whole Cell Cholera Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Whole Cell Cholera Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Whole Cell Cholera Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Whole Cell Cholera Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Whole Cell Cholera Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Whole Cell Cholera Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Whole Cell Cholera Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Whole Cell Cholera Vaccine, Established Date
- 3.9 Global Whole Cell Cholera Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson and Johnson
- 4.1.1 Johnson and Johnson Company Information
- 4.1.2 Johnson and Johnson Business Overview
- 4.1.3 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson and Johnson Whole Cell Cholera Vaccine Product Portfolio
- 4.1.5 Johnson and Johnson Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Whole Cell Cholera Vaccine Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Whole Cell Cholera Vaccine Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Valneva SE
- 4.5.1 Valneva SE Company Information
- 4.5.2 Valneva SE Business Overview
- 4.5.3 Valneva SE Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Valneva SE Whole Cell Cholera Vaccine Product Portfolio
- 4.5.5 Valneva SE Recent Developments
- 4.6 Serum Institute of India
- 4.6.1 Serum Institute of India Company Information
- 4.6.2 Serum Institute of India Business Overview
- 4.6.3 Serum Institute of India Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Serum Institute of India Whole Cell Cholera Vaccine Product Portfolio
- 4.6.5 Serum Institute of India Recent Developments
- 4.7 SBL Vaccine
- 4.7.1 SBL Vaccine Company Information
- 4.7.2 SBL Vaccine Business Overview
- 4.7.3 SBL Vaccine Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SBL Vaccine Whole Cell Cholera Vaccine Product Portfolio
- 4.7.5 SBL Vaccine Recent Developments
- 4.8 Sanofi Pasteur
- 4.8.1 Sanofi Pasteur Company Information
- 4.8.2 Sanofi Pasteur Business Overview
- 4.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Product Portfolio
- 4.8.5 Sanofi Pasteur Recent Developments
- 4.9 PaxVax
- 4.9.1 PaxVax Company Information
- 4.9.2 PaxVax Business Overview
- 4.9.3 PaxVax Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 PaxVax Whole Cell Cholera Vaccine Product Portfolio
- 4.9.5 PaxVax Recent Developments
- 4.10 AstraZeneca(Medimmune, LLC.)
- 4.10.1 AstraZeneca(Medimmune, LLC.) Company Information
- 4.10.2 AstraZeneca(Medimmune, LLC.) Business Overview
- 4.10.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Portfolio
- 4.10.5 AstraZeneca(Medimmune, LLC.) Recent Developments
5 Global Whole Cell Cholera Vaccine Market Scenario by Region
- 5.1 Global Whole Cell Cholera Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Whole Cell Cholera Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Whole Cell Cholera Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Whole Cell Cholera Vaccine Sales by Region: 2027-2032
- 5.3 Global Whole Cell Cholera Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Whole Cell Cholera Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Whole Cell Cholera Vaccine Revenue by Region: 2027-2032
- 5.4 North America Whole Cell Cholera Vaccine Market Facts & Figures by Country
- 5.4.1 North America Whole Cell Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Whole Cell Cholera Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Whole Cell Cholera Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Whole Cell Cholera Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Whole Cell Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Whole Cell Cholera Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Whole Cell Cholera Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Whole Cell Cholera Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Whole Cell Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Whole Cell Cholera Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Whole Cell Cholera Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Whole Cell Cholera Vaccine Market Facts & Figures by Country
- 5.7.1 South America Whole Cell Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Whole Cell Cholera Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Whole Cell Cholera Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Whole Cell Cholera Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Whole Cell Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Whole Cell Cholera Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Whole Cell Cholera Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Whole Cell Cholera Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Whole Cell Cholera Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Whole Cell Cholera Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Whole Cell Cholera Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Whole Cell Cholera Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Whole Cell Cholera Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Whole Cell Cholera Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Whole Cell Cholera Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Whole Cell Cholera Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Whole Cell Cholera Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Whole Cell Cholera Vaccine Value Chain Analysis
- 8.1.1 Whole Cell Cholera Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Whole Cell Cholera Vaccine Production Mode & Process
- 8.2 Whole Cell Cholera Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Whole Cell Cholera Vaccine Distributors
- 8.2.3 Whole Cell Cholera Vaccine Customers
9 Global Whole Cell Cholera Vaccine Analyzing Market Dynamics
- 9.1 Whole Cell Cholera Vaccine Industry Trends
- 9.2 Whole Cell Cholera Vaccine Industry Drivers
- 9.3 Whole Cell Cholera Vaccine Industry Opportunities and Challenges
- 9.4 Whole Cell Cholera Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst